CTA101 UCAR-T Cell Injection for Treatment of Relapsed or Refractory CD19+ B-cell Acute Lymphoblastic Leukemia
Clinical trial NCT04154709 · UNKNOWN
Trial details
- NCT number
- NCT04154709
- Sponsor
- Kai Lin Xu; Jun Nian Zheng
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-10
- Primary completion
- 2021-11-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.